M&A Deal Summary

ZOLL Medical Acquires ZOLL Circulation

On October 12, 2004, ZOLL Medical acquired medical products company ZOLL Circulation

Acquisition Highlights
  • This is ZOLL Medical’s 2nd transaction in the Medical Products sector.
  • This is ZOLL Medical’s 2nd transaction in the United States.
  • This is ZOLL Medical’s 2nd transaction in California.

M&A Deal Summary

Date 2004-10-12
Target ZOLL Circulation
Sector Medical Products
Buyer(s) ZOLL Medical
Deal Type Add-on Acquisition

Target

ZOLL Circulation

Sunnyvale, California, United States
ZOLL Circulation, Inc. is a provider of medical products in US.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

ZOLL Medical

Chelmsford, Massachusetts, United States

Category Company
Sector Medical Products
DESCRIPTION

ZOLL Medical Corporation develops and markets medical devices and software solutions that help advance emergency care and save lives, while increasing clinical and operational efficiencies. With products for defibrillation and monitoring, circulation and CPR feedback, data management, fluid resuscitation, and therapeutic temperature management, ZOLL provides a comprehensive set of technologies that help clinicians, EMS and fire professionals, and lay rescuers treat victims needing resuscitation and critical care.


DEAL STATS #
Overall 2 of 14
Sector: Medical Products M&A 2 of 10
Type: Add-on Acquisition M&A Deals 2 of 13
State: California M&A 2 of 4
Country: United States M&A 2 of 12
Year: 2004 M&A 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2004-10-12 Revivant

Sunnyvale, California, United States

Revivant Corp is a medical technology company that was founded to develop and market proprietary technology to treat sudden cardiac arrest both in and out of the hospital.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2009-02-20 Alsius

Chelmsford, Massachusetts, United States

Alsius Corporation is a proprietary technology targeting severe traumatic brain injury, ischemic stroke and cardiac arrest.

Buy $12M